Vaishali Pharma Limited

NSE VAISHALI.NS

Vaishali Pharma Limited Revenue Per Share for the year ending March 31, 2024: USD 0.97

Vaishali Pharma Limited Revenue Per Share is USD 0.97 for the year ending March 31, 2024, a 28.43% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Vaishali Pharma Limited Revenue Per Share for the year ending March 31, 2023 was USD 0.76, a -15.08% change year over year.
  • Vaishali Pharma Limited Revenue Per Share for the year ending March 31, 2022 was USD 0.89, a 31.88% change year over year.
  • Vaishali Pharma Limited Revenue Per Share for the year ending March 31, 2021 was USD 0.68, a -7.84% change year over year.
  • Vaishali Pharma Limited Revenue Per Share for the year ending March 31, 2020 was USD 0.73, a -25.66% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
SV Wall Street
NSE: VAISHALI.NS

Vaishali Pharma Limited

CEO Mr. Hemanth Damodar Pathak
IPO Date Aug. 22, 2017
Location India
Headquarters 706 to 709, Aravalli Business Center
Employees 27
Sector Healthcare
Industries
Description

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.

Similar companies

KREBSBIO.NS

Krebs Biochemicals & Industries Limited

USD 1.15

4.92%

ZOTA.NS

Zota Health Care Limited

USD 10.92

-0.24%

ALBERTDAVD.NS

Albert David Limited

USD 13.52

1.95%

BIOFILCHEM.NS

Biofil Chemicals and Pharmaceuticals Limited

USD 0.64

5.12%

StockViz Staff

February 2, 2025

Any question? Send us an email